Bill · H.R. 2343· House(119-HR-2343)

John W. Walsh Alpha-1 Home Infusion Act of 2025

Age: 65 years

Florida

Introduced: 3/25/2025
Last activity: 3/25/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by: Maria Salazar
Cosponsors: - 22 - 38

Health

Introduced
In Committee

What this bill would do

This bill is known as the John W. Walsh Alpha-1 Home Infusion Act of 2025. It amends the Social Security Act to provide Medicare coverage and payment for Alpha-1 Antitrypsin Deficiency Disorder treatment under part B. The treatment involves augmentation therapy furnished by qualified home infusion therapy suppliers directly in an individual's home. To qualify, individuals must be under the care of an applicable provider and enrolled in both parts A and B of Medicare while not being enrolled in a part C Medicare Advantage plan. The legislation also sets up a payment system for intravenous administration kits and up to two hours of nursing services. These changes are scheduled to apply to items and services furnished on or after January 1, 2027.

Yes· 3 of 5

Does this make health care easier to get in general?+8
The bill improves access to essential augmentation therapy through home-based infusion services.
Would people over 65 be better off under this?+7
The bill provides crucial Medicare coverage for chronic disease management, which primarily benefits seniors.
Would retired people be better off under this?+7
The expansion of Medicare Part B benefits directly supports the health needs of retirees.